Brassica Pharma Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
as on 15-12-2024
- Paid Up Capital ₹ 4.80 Cr
as on 15-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 15.09 Cr
as on 15-12-2024
- Satisfied Charges ₹ 34.94 Cr
as on 15-12-2024
- Revenue -4.71%
(FY 2022)
- Profit -48.16%
(FY 2022)
- Ebitda -32.88%
(FY 2022)
- Net Worth 2.55%
(FY 2022)
- Total Assets 9.43%
(FY 2022)
About Brassica Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 4.80 Cr.
The company currently has active open charges totaling ₹15.09 Cr. The company has closed loans amounting to ₹34.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Uday Chile and Jayashree Sirsavkar serve as directors at the Company.
- CIN/LLPIN
U24230MH2006PTC160053
- Company No.
160053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Feb 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Brassica Pharma Private Limited offer?
Brassica Pharma Private Limited offers a wide range of products and services, including Pharmaceutical Syrup, Liquid Orals, Digestive System Drugs & Medicines, Antacid Drugs.
Who are the key members and board of directors at Brassica Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Chile  | Director | 27-Feb-2006 | Current |
| Jayashree Sirsavkar | Director | 27-Feb-2006 | Current |
Financial Performance of Brassica Pharma.
Brassica Pharma Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.71% decrease. The company also saw a substantial fall in profitability, with a 48.16% decrease in profit. The company's net worth moved up by a moderate rise of 2.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Brassica Pharma?
Unlock access to Brassica Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Mar 2024 | ₹15.00 Cr | Open |
Others Creation Date: 31 Mar 2023 | ₹0.86 M | Open |
Abhyudaya Co-Operative Bank Limited Creation Date: 07 Jan 2022 | ₹1.50 Cr | Satisfied |
How Many Employees Work at Brassica Pharma?
Brassica Pharma has a workforce of 126 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Brassica Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Brassica Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
